A plain-language guide

Kawasaki disease

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Early map · 8 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. Kawasaki disease is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's Kawasaki disease?

Kawasaki disease is a severe acute inflammatory and febrile illness of children under five, with skin and mucous-membrane changes and lymph-node involvement, and a risk of coronary artery damage.

Features mapped6
Treatments mapped1
Published sources6
Last reviewed2026-08-04

Signs and symptoms

Vasculitis

Kawasaki disease is a systemic vasculitis (inflammation of blood vessels) that can damage the coronary arteries of the heart.

Limited evidenceSource: PMID:42145156
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42387075, ORPHA:2331
Notesplain_language confirmed from PMID:42387075 via curation 2026-07-03 [llm:fable-5]. | regrounded primary ORPHA:2331 -> PMID:42145156 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Cervical lymphadenopathy

Swollen neck lymph nodes (lymphadenopathy) are one of the features of Kawasaki disease.

Limited evidenceSource: PMID:41338893
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42345054, ORPHA:2331
Notesplain_language confirmed from PMID:42345054 via curation 2026-07-03 [llm:fable-5]. | regrounded primary ORPHA:2331 -> PMID:41338893 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Skin rash

Kawasaki disease produces skin and mucous-membrane changes, including rash.

Limited evidenceCurated reference: ORPHA:2331
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42345054
Notesplain_language confirmed from PMID:42345054 via curation 2026-07-03 [llm:fable-5].
Last reviewed2026-07-03

Edema

Limb edema (swelling) has been reported in a person with Kawasaki disease, described alongside persistent fever, skin redness (erythema), and conjunctivitis, and without neck lymph node swelling or the typical rash.

Limited evidenceSource: PMID:41441313
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:2331
Notesplain_language confirmed from PMID:41441313 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary ORPHA:2331 -> PMID:41441313 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Fever

A fever is a defining feature of Kawasaki disease, an acute febrile illness of young children.

Limited evidenceSource: PMID:41338893
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42345054, ORPHA:2331
Notesplain_language confirmed from PMID:42345054 via curation 2026-07-03 [llm:fable-5]. | regrounded primary ORPHA:2331 -> PMID:41338893 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Conjunctivitis

Conjunctivitis (eye inflammation) is among the findings used to recognize Kawasaki disease, and can appear together with cracked lips and throat redness (pharyngeal congestion).

Limited evidenceSource: PMID:41640915
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:2331
Notesplain_language confirmed from PMID:41640915 via curation 2026-07-03 [llm:claude-opus-4-8]. | regrounded primary ORPHA:2331 -> PMID:41640915 on 2026-07-03 [Carrie Schluter, BCPA]
Last reviewed2026-07-03

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

intravenous immunoglobulin

Intravenous immunoglobulin (IVIG) is the standard first-line treatment for acute Kawasaki disease and helps resolve the fever and inflammation.

Used to help with: Fever.

Limited evidenceSource: PMID:42159808
The source text this rests on
“Intravenous immunoglobulin (IVIG) at 2 g/kg is the standard first-line therapy for acute Kawasaki disease (KD), yet a subset of patients remains febrile after…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:42159808 via curation 2026-07-03
Last reviewed2026-07-03

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 6 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

ORPHA:2331 · Orphanet/HPO annotations for Kawasaki disease
PMID:41338893 · Febrile convulsion and cervical lymphadenopathy as initial presentation of incomplete node-first Kawasaki disease.
PMID:41441313 · Immunological Profile in Atypical Kawasaki Disease: A Case Report Highlighting the Diagnostic Utility of Cytokine Analysis by qRT-PCR.
PMID:41640915 · Refractory Kawasaki Disease With a Coronary Artery Aneurysm in a Three-Month-Old Infant: Diagnostic Challenges and Rescue With Infliximab.
PMID:42145156 · Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart Association.
PMID:42159808 · Early post-IVIG serum IgG concentration does not explain IVIG non-response in Kawasaki disease.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.